Craig Coleman
Professor/Pharmacy Practice
Storrs Mansfield
Are you Craig Coleman?
How to update your information.
Scholarly Contributions
620 Scholarly Contributions
Ophthalmic Complications in Patients with Nonvalvular Atrial Fibrillation and Type 2 Diabetes Prescribed Rivaroxaban or Warfarin
2021
Research Type: Poster/Presentation
Stroke, Systemic Embolism, Vascular Death and Bleeding in Nonvalvular Atrial Fibrillation Patients with Type 2 Diabetes Receiving Rivaroxaban or Warfarin
2021
Research Type: Poster/Presentation
Ophthalmic complications in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin.
2021
Research Type: Poster/Presentation
Thromboembolism, bleeding, and vascular death among older and younger nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin.
2021
Research Type: Poster/Presentation
Characterizing safety and efficacy in ovarian cancer patients with thromboembolism treated with rivaroxaban.
2021
Research Type: Poster/Presentation
Interview with the expert: RIVA-DM – What do recent data tell us?
2021
Research Type: Poster/Presentation
Kidney, limb and ophthalmic complications and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: An electronic health record analysis.
2021
Research Type: Poster/Presentation
Patient characteristics and temporal changes in anticoagulation treatment patterns in patients diagnosed with cancer-associated thrombosis: An oscar-us analysis.
2021
Research Type: Poster/Presentation
Kidney, Limb and Ophthalmic Complications and Death in Patients with Nonvalvular Atrial Fibrillation Prescribed Rivaroxaban or Warfarin: An Electronic Health Record Analysis
2021
Research Type: Poster/Presentation
Do differences in baseline clinical severity of ovarian cancer patients with thrombosis predict treatment with rivaroxaban versus low molecular-weight heparin?.
2021
Research Type: Poster/Presentation
Real-World Hemostatic Effectiveness of Andexanet Alfa for Management of Intracerebral Hemorrhage
2020
Research Type: Poster/Presentation
“OUTCOMES ASSOCIATED WITH BLEEDING-RELATED HOSPITALIZATIONS IN PATIENTS AT HIGH THROMBOTIC RISK FINDINGS FROM THE NATIONWIDE READMISSION DATABASE”. Event: ACC 2020, Chicago.
2020
Research Type: Poster/Presentation
Does Rivaroxaban Reduce the Development of Renal failure Compared to Vitamin K Antagonist Use in Nonvalvular Atrial Fibrillation Patients? A Systematic Review and Meta-Analysis
2020
Research Type: Poster/Presentation
Methodological and Reporting Quality in Case Series of Four-Factor Prothrombin Complex Concentrate in the Management of Oral Factor Xa Inhibitor-Associated Bleeding,
2020
Research Type: Poster/Presentation
Does one size fits all for NVAF patients with comorbidities?
2020
Research Type: Poster/Presentation
“Four-Year Incidence of Major Adverse Cardiovascular Events in Patients With Established Cerebrovascular Disease”. Event: ISC 2020, Los Angeles.
2020
Research Type: Poster/Presentation
Rivaroxaban Versus Warfarin for Treatment and Prevention of Recurrent Venous Thromboembolism in Obese Patients
2020
Research Type: Poster/Presentation
Do Difference in Baseline Clinical Severity of Oral Factor Xa Inhibitor-Associated Intracranial Hemorrhage Predict Andexanet Versus Four-Factor Prothrombin Complex Concentrate Administration?
2020
Research Type: Poster/Presentation
“RIVAROXABAN VERSUS WARFARIN IN AFRICAN AMERICAN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION”. Event: ACC 2020, Chicago.
2020
Research Type: Poster/Presentation